Results 231 to 240 of about 614,691 (404)
Molecular Oncology, EarlyView.We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
"I don't see myself represented here at all": User Experiences of Stable Diffusion Outputs Containing Representational Harms across Gender Identities and Nationalities [PDF]
Sourojit Ghosh +2 more
openalex +1 more source
Ethnicity and nationality in the Irish labour market
, 2018 F. McGinnity +3 more
semanticscholar +1 more source
Name Nationality Classification with Recurrent Neural Networks
International Joint Conference on Artificial Intelligence, 2017 Jinhyuk Lee +5 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
The collection and integration of data on migrants in health information systems: evidence from Ireland. [PDF]
Int J Equity HealthVishwakarma D +7 more
europepmc +1 more source
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source